SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.400+1.7%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Fitzhughlaw
jargonweary
Stanley Lake 92
sukit
To: bobbseytwins2001 who wrote (1135)8/15/2025 3:16:25 PM
From: galt4 Recommendations   of 1216
 
Agree to disagree.
I see a number of changes in PSS, having followed him for a long time.
Seems headed down a rabbit hole of late.
Agree his checking account could do wonders for the share price.
Maybe he should use it, as a share price at 7, let’s say,
Would do wonders, imo.
Don’t overestimate past performance as the indicator of future performance.
There are a number of big bios, imo, that need and would
Probably pay a significant premium IF PSS was the leader of old.
Something is amiss, imo.
Anyway, I, like you, patiently wait for that time that you suggest he will
Drive the price up.
Performance blended with a strong mix of investors usually helps.
IMMU was a clear example of it.
Thanks for your thoughts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext